Ray Dalio's FOLD Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 32,274 shares of Amicus Therapeutics, Inc. (FOLD) worth $459,582, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in FOLD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +32,274 | New Buy | 32,274 | $14.24 |
Ray Dalio's Amicus Therapeutics Investment FAQs
Ray Dalio first purchased Amicus Therapeutics, Inc. (FOLD) in Q4 2025, acquiring 32,274 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Amicus Therapeutics, Inc. (FOLD) for 1 quarters since Q4 2025.
Ray Dalio's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q4 2025, adding 32,274 shares worth $459,582.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 32,274 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $459,582.
As of the Q4 2025 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Amicus Therapeutics, Inc. (FOLD) was 32,274 shares, as reported at the end of Q4 2025.